Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
MHY1485: Designing Causal mTOR Assays
2026-09-22
MHY1485 is an mTOR activator for dissecting autophagy, metabolic signaling, and ovarian follicle development. This guide focuses on causal assay design, flux interpretation, and how the Anti-b study can sharpen—not replace—MHY1485 experimental decisions.
-
Bafilomycin A1 in Endosomal Escape Assays
2026-09-22
Use Bafilomycin A1 as a reversible V-ATPase inhibitor to dissect acidification, lysosomal degradation, and endosomal escape in mRNA delivery experiments. This workflow combines nanomolar dose-finding, orthogonal trafficking readouts, and controls that distinguish reduced uptake from impaired intracellular release.
-
Ruthenium Red: A Calcium Lens on Mechanotransduction
2026-09-21
A translational framework for using Ruthenium Red as a broad Ca2+ transport inhibitor to test how calcium signaling intersects with cytoskeleton-dependent autophagy, mechanical stress, mitochondrial function, and neurogenic inflammation.
-
Bsa I (RNase-free): Practical Workflow Guide
2026-09-21
Bsa I (RNase-free) provides sequence-directed DNA cleavage for gene cloning, DNA manipulation, and other molecular biology research workflows where RNA contamination should be minimized. It is supplied with 10X Cut rA Buffer for research use only and is not intended for diagnostic, clinical, or medical applications.
-
5-(N,N-dimethyl)-Amiloride for Endothelial Research
2026-09-20
5-(N,N-dimethyl)-Amiloride hydrochloride provides a practical way to separate Na+/H+ exchanger-dependent ion flux from endothelial injury signals in cell and tissue models. This article outlines pilot dosing, pH and permeability readouts, cardiac translation, and troubleshooting strategies anchored to sepsis biomarker research.
-
Sulfo-NHS-SS-Biotin: Reliable Surface Labeling
2026-09-19
A scenario-based guide to using Sulfo-NHS-SS-Biotin (SKU A8005) for cell-surface protein labeling, affinity purification, and orthogonal interpretation of viability or cytotoxicity experiments. It explains reagent compatibility, fresh-solution handling, disulfide cleavage, data controls, and practical vendor-selection criteria.
-
AAPH Oxidative Stress Assays: Practical Workflows
2026-09-18
AAPH provides sustained, water-compatible peroxyl-radical generation for erythrocyte hemolysis, lipid peroxidation, protein oxidation, and antioxidant screening. This guide translates a hazelnut-protein oxidation study into practical assay design, dose selection, controls, and troubleshooting strategies.
-
From Tau Ser356 to Translational Decision-Making
2026-09-18
Taylor and colleagues’ study of tau phosphorylated at Ser356 illustrates why target engagement, tissue context, and preservation of neuronal integrity must be evaluated together. This article translates those findings into a practical framework for using human brain slices and positioning Linagliptin (BI-1356) as a carefully controlled, orthogonal research compound.
-
dhcr7 Knockout Grass Carp and GCRV Resistance
2026-09-17
A 2026 Aquaculture Reports study used CRISPR/Cas9 to generate dhcr7-disrupted grass carp and demonstrate in vivo resistance to genotype II grass carp reovirus. The work connects cholesterol biosynthesis with antiviral immunity, reduced viral burden, and protection of the hepatopancreas without detectable growth or muscle abnormalities.
-
Cy3 Secondary Antibody for Translational Research
2026-09-17
Translational antibody programs need more than potent binders: they need assay architectures that connect epitope discovery, cellular localization, tissue evidence, and functional interpretation. This thought-leadership article examines how a Cy3 conjugated secondary antibody can strengthen human IgG detection while supporting research on orthopoxvirus antibody cocktails and bispecific formats. It also defines practical controls, workflow parameters, competitive considerations, and the limitations that separate an informative detection reagent from evidence of therapeutic protection.
-
Preclinical Models of Anti-PD-1 Interstitial Pneumonia
2026-09-16
Luo and colleagues developed complementary in vitro and in vivo models of anti-PD-1-related interstitial pneumonia, addressing a major gap in immune-related adverse event research. Their organoid–PBMC, lung epithelial cell–PBMC, and PD-1-humanized mouse systems reproduced inflammatory and fibrotic lung injury and provide practical platforms for mechanism and intervention studies.
-
Cy7 NHS Ester: Practical Labeling Guide
2026-09-16
Cy7 NHS ester (SKU A8109) is a water-soluble protein labeling dye for attaching near-infrared fluorescence to primary amines on proteins, peptides, and related biomolecules. It is suited to aqueous labeling and near-infrared fluorescent imaging, but freshly prepared solutions, NHS-compatible buffers, purification, and conjugate-specific validation are required.
-
NF-κB–YAP Control of Pyroptosis in Ulcerative Colitis
2026-09-15
The reference study identifies a regulatory circuit in which NF-κB p65 activates LATS1, inactivates YAP, and releases YAP-mediated repression of NLRP3 in colonic epithelial cells. Its combination of epithelial cell models, DSS colitis, GSDMD genetic ablation, YAP overexpression, nuclear fractionation, and chromatin immunoprecipitation provides a mechanistic framework for linking inflammatory signaling to pyroptotic tissue injury.
-
ML-7 Hydrochloride: MLCK Research Workflows
2026-09-15
ML-7 hydrochloride provides a pathway-focused way to interrogate myosin light chain kinase signaling in cardiac injury, endothelial barrier, and contractility assays. This guide combines target-engagement controls with a reference-inspired cell-entry framework while clearly separating established cardiovascular applications from exploratory infection-model extensions.
-
ABT-199 (Venetoclax): Selective Bcl-2 Inhibition
2026-09-14
ABT-199, also called Venetoclax or GDC-0199, is a potent and selective BCL-2 inhibitor for laboratory apoptosis and hematologic malignancy research. Its product-reported selectivity supports mechanistic studies of BCL-2-dependent cell survival, while solvent handling and research-use limitations remain essential for interpretation.